Myovant Starts Phase 3 Clinical Trials of Relugolix as Endometriosis Pain Reliever
News
Myovant Sciences has started a Phase 3 clinical trial program to see if its therapy relugolix can reduce endometriosis-associated pain. It plans two trials that investigate the safety and effectiveness of relugolix, with ... Read more